10.1016/s0140-6736(03)14416-9
Crossref journal-article
Elsevier BV
The Lancet (78)
Bibliography

Calverley, P., & Walker, P. (2003). Chronic obstructive pulmonary disease. The Lancet, 362(9389), 1053–1061.

Authors 2
  1. PMA Calverley (first)
  2. Paul Walker (additional)
References 127 Referenced 184
  1. 10.1016/S0140-6736(96)07493-4 / Lancet / Mortality by cause for eight regions of the world: Global Burden of Disease Study by Murray (1997)
  2. 10.1016/S0140-6736(96)07495-8 / Lancet / Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study by Murray (1997)
  3. 10.1016/S0140-6736(96)07492-2 / Lancet / Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study by Murray (1997)
  4. {'key': '10.1016/S0140-6736(03)14416-9_bib4', 'series-title': 'The Global Burden of Disease 2000 Project: global programme on evidence for health policy discussion, paper number 36', 'author': 'Murray', 'year': '2001'} / The Global Burden of Disease 2000 Project: global programme on evidence for health policy discussion, paper number 36 by Murray (2001)
  5. National Centre for Health Statistics. National hospital interview survey. Vital and Health Statistics, series 10 (issues from 1974 to 1997).
  6. 10.1136/thorax.55.9.789 / Thorax / Recent trends in physician diagnosed COPD in women and men in the UK by Soriano (2000)
  7. Lung and Asthma Information Agency. Trends in emergency hospital admissions for lung disease. Fact sheet 2001/4. London: St George's Hospital Medical School.
  8. 10.1164/ajrccm/145.6.1321 / Am Rev Respir Dis / A self-complete measure of health status for chronic airflow limitation: the St George's respiratory questionnaire by Jones (1992)
  9. 10.1001/archinte.1982.00340160057014 / Arch Intern Med / Life quality of patients with chronic obstructive pulmonary disease by McSweeny (1982)
  10. 10.1136/thx.51.1.39 / Thorax / Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease by Ketelaars (1996)
  11. 10.1164/ajrccm.157.3.9703055 / Am J Respir Crit Care Med / Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease by Hajiro (1998)
  12. {'key': '10.1016/S0140-6736(03)14416-9_bib13', 'series-title': 'Living with COPD: results of the British Lung Foundation survey', 'author': 'Morgan', 'year': '2001'} / Living with COPD: results of the British Lung Foundation survey by Morgan (2001)
  13. 10.1183/09031936.02.03242002 / Eur Respir J / The impact of COPD in North America and Europe in 2000: the patients perspective of the Confronting COPD International Survey by Rennard (2002)
  14. 10.1164/ajrccm/136.1.225 / AmRev Respir Dis / Standards for the diagnosis of patients with chronic obstructive pulmonary disease (COPD) and asthma (1987)
  15. {'key': '10.1016/S0140-6736(03)14416-9_bib16', 'first-page': '420', 'article-title': 'Guidelines for the assessment and management of chronic obstructive pulmonary disease', 'volume': '147', 'year': '1992', 'journal-title': 'Can Med Assoc J'} / Can Med Assoc J / Guidelines for the assessment and management of chronic obstructive pulmonary disease (1992)
  16. 10.1183/09031936.95.08081398 / Eur Respir J / Optimal assessment and management of chronic obstructive pulmonary disease (1995)
  17. 10.1136/thx.52.suppl_5.1 / Thorax / BTS guidelines for the management of chronic obstructive pulmonary disease (1997)
  18. 10.1164/ajrccm.163.5.2101039 / Am J Respir Crit Care Med / Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary by Pauwels (2001)
  19. 10.1136/bmj.1.6077.1645 / BMJ / The natural history of chronic airflow obstruction by Fletcher (1977)
  20. 10.1164/arrd.1983.128.3.491 / Am Rev Respir Dis / The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease: results from 20 years of prospective observation by Peto (1983)
  21. {'key': '10.1016/S0140-6736(03)14416-9_bib22', 'first-page': '471', 'article-title': 'Domestic smoke pollution and respiratory function in rural Nepal', 'volume': '10', 'author': 'Pandey', 'year': '1985', 'journal-title': 'Tokai J Exp Clin Med'} / Tokai J Exp Clin Med / Domestic smoke pollution and respiratory function in rural Nepal by Pandey (1985)
  22. 10.1136/thx.39.5.331 / Thorax / Prevalence of chronic bronchitis in a rural community of the hill region of Nepal by Pandey (1984)
  23. 10.1164/ajrccm.154.3.8810608 / Am J Respir Crit Care Med / Exposure to biomass smoke and chronic airway disease in Mexican women: a case-control study by Perez-Padilla (1996)
  24. 10.1056/NEJM197806082982303 / N Engl J Med / The relations between structural changes in small airways and pulmonary function tests by Cozio (1978)
  25. {'key': '10.1016/S0140-6736(03)14416-9_bib26', 'series-title': 'Chronic airflow obstruction', 'author': 'Thurlbeck', 'year': '1999'} / Chronic airflow obstruction by Thurlbeck (1999)
  26. {'key': '10.1016/S0140-6736(03)14416-9_bib27', 'first-page': '536', 'article-title': 'The progress of chronic airway obstruction in relation to measurements of airway resistance and lung elastic recoil', 'volume': '101', 'author': 'Penman', 'year': '1970', 'journal-title': 'Am Rev Respir Dis'} / Am Rev Respir Dis / The progress of chronic airway obstruction in relation to measurements of airway resistance and lung elastic recoil by Penman (1970)
  27. 10.1152/jappl.1973.34.2.143 / J Appl Physiol / Pulmonary conductance and elastic recoil relationships in asthma and emphysema by Colebatch (1973)
  28. 10.1164/ajrccm.153.2.8564092 / JRespir Crit Care Med / Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma by Keatings (1996)
  29. 10.1183/09031936.98.12020380 / Eur Respir J / Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease by Pesci (1998)
  30. 10.1164/rccm.2111084 / Am J Respir Crit Care Med / Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema by Turato (2002)
  31. 10.1164/ajrccm.160.2.9812020 / Am J Respir Crit Care Med / CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease by Saetta (1999)
  32. 10.1164/ajrccm.155.3.9117016 / Am J Respir Crit Care Med / Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T-lymphocytes with FEV1 by O'Shaughnessy (1997)
  33. 10.1164/ajrccm.164.3.2007149 / Am J Respir Crit Care Med / Amplification of inflammation in emphysema and its association with latent adenoviral infection by Retamales (2001)
  34. 10.1164/rccm.200203-183OC / Am J Respir Crit Care Med / Differences in airway inflmmation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease by Fabbri (2003)
  35. 10.1172/JCI0216782 / J Clin Invest / Alpha 1 antitrypsin polymerisation and the serpinopathies: pathobiology and prospects for treatment by Lomas (2002)
  36. 10.1164/ajrccm.163.4.2001108 / Am J Respir Crit Care Med / Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases by Corradi (2001)
  37. 10.1164/ajrccm.162.3.2001063 / Am J Respir Crit Care Med / Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers by Montuschi (2000)
  38. 10.1016/0092-8674(92)90391-O / Cell / Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema by D'Armiento (1992)
  39. 10.1165/ajrcmb.20.2.3305 / Am J Respir Cell Mol Biol / Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappa B activation and IL-8 mRNA expression in guinea pigs in vivo by Nishikawa (1999)
  40. 10.1126/science.277.5334.2002 / Science / Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice by Hautamaki (1997)
  41. 10.1172/JCI10458 / J Clin Invest / Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase–and cathepsin-dependent emphysema by Zheng (2000)
  42. 10.1164/ajrccm.163.3.2002117 / Am J Respir Crit Care Med / Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema by Kasahara (2001)
  43. 10.1136/thorax.57.8.736 / Thorax / Chronic obstructive pulmonary disease: 1–susceptibility factors for COPD the genotype-environment interaction by Sandford (2002)
  44. 10.1164/ajrccm.157.6.9706014 / Am J Respir Crit Care Med / Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis by Silverman (1998)
  45. 10.1164/ajrccm.164.8.2105002 / AmJRespir Crit Care Med / Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction by McCloskey (2001)
  46. 10.1002/0470868678.ch15 / Novartis Found Symp / Systemic effects of chronic obstructive pulmonary disease by Agusti (2001)
  47. 10.1164/ajrccm.157.6.9705017 / Am J Respir Crit Care Med / Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease by Schols (1998)
  48. 10.1164/ajrccm.159.supplement_2.mfa-1 / AmJRespir Crit Care Med / Skeletal muscle dysfunction in chronic obstructive pulmonary disease (1999)
  49. 10.1378/chest.117.5_suppl_1.219S-a / Chest / Expiratory flow limitation: Roger S Mitchell Lecture by Milic-Emili (2000)
  50. 10.1164/ajrccm.164.5.2012122 / AmJRespir Crit Care Med / Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease by O'Donnell (2001)
  51. 10.1164/ajrccm.160.2.9901038 / Am J Respir Crit Care Med / Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease by O'Donnell (1999)
  52. 10.1164/ajrccm.163.4.2007026 / Am J Respir Crit Care Med / Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease by O'Donnell (2001)
  53. 10.1034/j.1399-3003.2000.16b14.x / Eur Respir J / Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest by Diaz (2000)
  54. 10.1164/ajrccm.159.6.9804136 / Am J Respir Crit Care Med / Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease by Sala (1999)
  55. 10.1164/ajrccm.159.4.9807121 / AmJRespir Crit Care Med / Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease by Hansen (1999)
  56. 10.1136/thx.52.1.67 / Thorax / Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease by Osman (1997)
  57. 10.1136/thx.54.7.581 / Thorax / Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease by Bestall (1999)
  58. 10.1378/chest.121.5.1434 / Chest / Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD by Nishimura (2002)
  59. 10.1164/rccm.2112043 / Am J Respir Crit Care Med / Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease by Domingo-Salvany (2002)
  60. 10.1164/ajrccm.163.4.2007048 / AmJRespir Crit Care Med / Exercise capacity predicts health status in alpha-1-antitrypsin deficiency by Dowson (2001)
  61. 10.1164/rccm.2112096 / Am J Respir Crit Care Med / Smoking and lung function of Lung Health Study participants after 11 years by Anthonisen (2002)
  62. 10.1164/ajrccm.163.1.2005009 / Am J Respir Crit Care Med / Health status deterioration in patients with chronic obstructive pulmonary disease by Spencer (2001)
  63. 10.1136/bmj.321.7257.355 / BMJ / Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library by Lancaster (2000)
  64. 10.1016/S0140-6736(00)04724-3 / Lancet / Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial by Tashkin (2001)
  65. 10.1001/jama.1994.03520190043033 / JAMA / Effects of smoking intervention and the use of an inhaled anti-cholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study by Anthonisen (1994)
  66. 10.1056/NEJMra010772 / N Engl J Med / Alpha1-antitrypsin deficiency: a model for conformational diseases by Carrell (2002)
  67. 10.1164/ajrccm.160.5.9901055 / Am J Respir Crit Care Med / A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy by Dirksen (1999)
  68. 10.1164/ajrccm.163.5.9903053 / Am J Respir Crit Care Med / Use of a long-acting inhaled beta 2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease by Rennard (2001)
  69. 10.1164/ajrccm.155.4.9105068 / Am J Respir Crit Care Med / Quality of life changes in COPD patients treated with salmeterol by Jones (1997)
  70. Dahl R, Greefhorst LAPM, Nowak D, et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164; 5: 778–84. (10.1164/ajrccm.164.5.2007006)
  71. 10.1378/chest.115.4.957 / Chest / Efficacy of salmeterol xinafoate in the treatment of COPD by Mahler (1999)
  72. 10.1183/09031936.02.00269802 / Eur Respir J / A long-term evaluation of once-daily inhaled tiotropium in chronic obsrtructive pulmonary disease by Casaburi (2002)
  73. 10.1183/09031936.02.00238702 / Eur Respir J / Improved health outcomes in patients with COPD during 1 year's treatment with tiotropium by Vincken (2002)
  74. 10.1378/chest.122.1.47 / Chest / A 6 month placebo controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol by Donohue (2002)
  75. 10.1164/ajrccm.161.2.16125_1 / Am J Respir Crit Care Med / Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease by Calverley (2000)
  76. 10.1164/ajrccm.161.2.16125_2 / Am J Respir Crit Care Med / Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease by Barnes (2000)
  77. 10.1056/NEJM199906243402503 / N Engl J Med / Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking by Pauwels (1999)
  78. 10.1016/S0140-6736(98)10019-3 / Lancet / Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial by Vestbo (1999)
  79. 10.1136/bmj.320.7245.1297 / BMJ / Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial by Burge (2000)
  80. 10.1056/NEJM200012283432601 / N Engl J Med / Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease (2000)
  81. 10.1164/ajrccm.164.4.2009033 / Am J Respir Crit Care Med / Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease by Sin (2001)
  82. 10.1183/09031936.02.00301302 / Eur Respir J / Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice by Soriano (2002)
  83. 10.1164/rccm.2112055 / Am J Respir Crit Care Med / Effectiveness of fluticasone propionate and salmeterol combination delivered via the diskus device in the treatment of chronic obstructive pulmonary disease by Mahler (2002)
  84. 10.1016/S0140-6736(03)12459-2 / Lancet / Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial by Calverley (2003)
  85. 10.1183/09031936.03.00031402 / Eur Respir J / Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease by Szafranski (2003)
  86. 10.1164/ajrccm.159.5.ats2-99 / Am J Respir Crit Care Med / Pulmonary rehabilitation (1999)
  87. 10.1136/thorax.56.11.827 / Thorax / Pulmonary rehabilitation (2001)
  88. 10.1016/S0140-6736(94)90568-1 / Lancet / Randomised controlled trial of respiratory rehabilitation by Goldstein (1994)
  89. 10.1183/09031936.94.07020269 / Eur Respir J / Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home by Wijkstra (1994)
  90. 10.1111/j.1445-5994.1999.tb01589.x / Aust N Z J Med / Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programme by Young (1999)
  91. 10.1164/ajrccm.160.4.9901014 / Am J Respir Crit Care Med / Exercise rehabilitation and chronic obstructive pulmonary disease stage by Berry (1999)
  92. 10.1016/S0140-6736(99)07042-7 / Lancet / Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial by Griffiths (2000)
  93. {'key': '10.1016/S0140-6736(03)14416-9_bib94', 'series-title': 'Domiciliary oxygen therapy services: clinical guidelines and advice for prescribers', 'year': '1999'} / Domiciliary oxygen therapy services: clinical guidelines and advice for prescribers (1999)
  94. 10.7326/0003-4819-93-3-391 / Ann Intern Med / Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial (1980)
  95. {'key': '10.1016/S0140-6736(03)14416-9_bib96', 'first-page': '681', 'article-title': 'Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema', 'volume': '1', 'year': '1981', 'journal-title': 'Lancet'} / Lancet / Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema (1981)
  96. 10.1136/thx.52.8.674 / Thorax / Effect of long-term oxygen therapy on survival of patients with chronic obstructive pulmonary disease with moderate hypoxaemia by Gorecka (1997)
  97. 10.1136/thx.51.8.831 / Thorax / Comparison of the efficacy of a demand oxygen delivery system with continuous low flow oxygen in subjects with stable COPD and severe oxygen desaturation on walking by Roberts (1996)
  98. {'key': '10.1016/S0140-6736(03)14416-9_bib99', 'series-title': 'The Cochrane Library. Issue 2', 'article-title': 'Ambulatory oxygen for chronic obstructive pulmonary disease (Cochrane Review)', 'author': 'Ram', 'year': '2003'} / The Cochrane Library. Issue 2 / Ambulatory oxygen for chronic obstructive pulmonary disease (Cochrane Review) by Ram (2003)
  99. 10.1164/ajrccm.160.6.9902117 / AmJRespir Crit Care Med / Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease by Criner (1999)
  100. 10.1056/NEJM200007273430402 / N Engl J Med / Effect of lung-volume-reduction surgery in patients with severe emphysema by Geddes (2000)
  101. 10.1056/NEJMoa11798 / N Engl J Med / Patients at high risk of death after lung-volume-reduction surgery (2001)
  102. 10.1056/NEJMoa030287 / N Engl J Med / A randomised trial comparing lung volume reduction surgery with medical therapy for severe emphysema (2003)
  103. 10.1016/S0140-6736(97)06405-2 / Lancet / Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease by Hosenpud (1998)
  104. 10.1136/heart.87.5.449 / Heart / Intrathoracic organ transplantation in the United Kingdom 1995–99: results from the UK cardiothoracic transplant audit by Anyanwu (2002)
  105. 10.1378/chest.117.5_suppl_2.398S / Chest / Toward a consensus definition for COPD exacerbations by Rodriguez-Roisin (2000)
  106. 10.1164/ajrccm.157.5.9709032 / Am J Respir Crit Care Med / Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease by Seemungal (1998)
  107. 10.1136/thorax.57.10.847 / Thorax / Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease by Donaldson (2002)
  108. 10.1164/ajrccm.164.9.2105011 / Am J Respir Crit Care Med / Symptoms, inflammatory markers and respiratory viruses in acute exacerbations and stable COPD by Seemungal (2001)
  109. 10.1164/ajrccm.152.4.7551388 / Am J Respir Crit Care Med / Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush by Monso (1995)
  110. 10.1164/ajrccm.157.5.9711044 / Am J Respir Crit Care Med / Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation by Soler (1998)
  111. 10.1378/chest.118.6.1557 / Chest / Airway inflammation and etiology of acute exacerbations of chronic bronchitis by Sethi (2000)
  112. 10.1136/thorax.57.9.759 / Thorax / Relationship between bacterial colonisation and the frequency, character and severity of COPD exacerbations by Patel (2002)
  113. 10.1164/ajrccm.154.2.8756814 / Am J Respir Crit Care Med / Controlled trial of oral prednisone in outpatients with acute COPD exacerbation by Thompson (1996)
  114. 10.1016/S0140-6736(98)11326-0 / Lancet / Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial by Davies (1999)
  115. 10.1056/NEJM199906243402502 / N Engl J Med / Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease by Niewoehner (1999)
  116. 10.1164/ajrccm.165.5.2109093 / Am J Respir Crit Care Med / Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial by Maltais (2002)
  117. 10.1136/thorax.55.7.550 / Thorax / One-year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administration by Plant (2000)
  118. 10.1164/ajrccm.154.4.8887592 / AmJRespir Crit Care Med / Outcomes following acute exacerbation of severe chronic obstructive lung disease by Connors (1996)
  119. 10.1016/S0140-6736(97)11048-0 / Lancet / Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service by Gravil (1998)
  120. 10.1136/bmj.321.7271.1265 / BMJ / Hospital at home versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial by Davies (2000)
  121. 10.1136/thorax.55.11.907 / Thorax / Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease by Skwarska (2000)
  122. 10.1136/thorax.55.11.902 / Thorax / Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial by Cotton (2000)
  123. 10.1136/thorax.57.2.167 / Thorax / Patients' and carers' preferences in two models of care for acute exacerbations of COPD: results of a randomised controlled trial by Ojoo (2002)
  124. 10.1136/thorax.57.3.192 / Thorax / Non-invasive ventilation in acute respiratory failure (2002)
  125. 10.1016/S0140-6736(00)02323-0 / Lancet / Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial by Plant (2000)
  126. 10.1056/NEJM199509283331301 / NEngl J Med / Non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease by Brochard (1995)
  127. 10.1016/S0140-6736(01)05481-2 / Lancet / Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study by Compton (2001)
Dates
Type When
Created 21 years, 10 months ago (Oct. 9, 2003, 1:21 a.m.)
Deposited 6 years, 6 months ago (Feb. 22, 2019, 9:58 a.m.)
Indexed 4 weeks ago (Aug. 5, 2025, 8:37 a.m.)
Issued 22 years ago (Sept. 1, 2003)
Published 22 years ago (Sept. 1, 2003)
Published Print 22 years ago (Sept. 1, 2003)
Funders 0

None

@article{Calverley_2003, title={Chronic obstructive pulmonary disease}, volume={362}, ISSN={0140-6736}, url={http://dx.doi.org/10.1016/s0140-6736(03)14416-9}, DOI={10.1016/s0140-6736(03)14416-9}, number={9389}, journal={The Lancet}, publisher={Elsevier BV}, author={Calverley, PMA and Walker, Paul}, year={2003}, month=sep, pages={1053–1061} }